mutares achieved record results in the first 9 months of 2015

The mutares Group (ISIN: DE000A0SMSH2) increased its revenues to EUR 475.3m and its operative earnings (EBITDA) significantly to EUR 19.2m in the first nine months of 2015 thus reaching new record levels.

In the first nine months of 2015, mutares increased its consolidated revenues by 6.0% to EUR 475.3m (2014: EUR 448.5m). All portfolio companies with the exception of Pixmania achieved significant organic growth. In particular, the development of the core holdings EUPEC, STS Acoustics, Elastomer Solutions, and Geesinknorba was very positive.

A+F significantly contributed to the increase in turnover as well as the recently acquired companies Zanders, BSL, and Grosbill. A decreasing effect in turnover was caused by the two successful exits of CGVL and Suir Pharma Ireland. The consolidated operative earnings (EBITDA) increased considerably to EUR 19.2m (2014: EUR 11.0m). The positive development reflects the success in the repositioning of mutares’ portfolio companies. Particularly EUPEC and STS contributed excellent results.

The market for companies in special situations still shows extraordinary dynamics. The attractive transaction pipeline of mutares indicates intensified acquisition activities in the future.